These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus. Askanase AD; Furie RA Adv Ther; 2022 Jul; 39(7):3088-3103. PubMed ID: 35641860 [TBL] [Abstract][Full Text] [Related]
23. Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis: A Narrative Review. Mirsaeidi M; Baughman RP Pulm Ther; 2022 Mar; 8(1):43-55. PubMed ID: 35113366 [TBL] [Abstract][Full Text] [Related]
24. Real-world treatment patterns for repository corticotropin injection in patients with rheumatoid arthritis. Busch H; Wan GJ; Niewoehner J; Houston P; Su Y; Clinton C; Panaccio MP Drugs Context; 2022; 11():. PubMed ID: 35382109 [TBL] [Abstract][Full Text] [Related]
26. Repository corticotropin injection in patients with advanced symptomatic sarcoidosis: retrospective analysis of medical records. Chopra I; Qin Y; Kranyak J; Gallagher JR; Heap K; Carroll S; Wan GJ Ther Adv Respir Dis; 2019; 13():1753466619888127. PubMed ID: 31722624 [TBL] [Abstract][Full Text] [Related]
27. Acthar Gel (repository corticotropin injection) for persistently active SLE: study design and baseline characteristics from a multicentre, randomised, double-blind, placebo-controlled trial. Askanase AD; Zhao E; Zhu J; Connolly-Strong E; Furie RA Lupus Sci Med; 2020; 7(1):e000383. PubMed ID: 32399253 [TBL] [Abstract][Full Text] [Related]
28. Adrenocorticotropin(1-10) and -(11-24) promote adrenal steroidogenesis by different mechanisms. Li ZG; Park D; LaBella FS Endocrinology; 1989 Aug; 125(2):592-6. PubMed ID: 2546738 [TBL] [Abstract][Full Text] [Related]
29. Effect of maternal infusion of adrenocorticotrophin1-24 (ACTH1-24) on parturition in guinea-pigs near term. Schellenberg JC Reprod Fertil Dev; 1997; 9(8):811-4. PubMed ID: 9733065 [TBL] [Abstract][Full Text] [Related]
30. Adrenal function in the cat: comparison of the effects of cosyntropin (synthetic ACTH) and corticotropin gel stimulation. Peterson ME; Kintzer PP; Foodman MS; Piccolie A; Quimby FW Res Vet Sci; 1984 Nov; 37(3):331-3. PubMed ID: 6097968 [TBL] [Abstract][Full Text] [Related]
31. Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. Askanase AD; Zhao E; Zhu J; Bilyk R; Furie RA Rheumatol Ther; 2020 Dec; 7(4):893-908. PubMed ID: 32996096 [TBL] [Abstract][Full Text] [Related]
33. Post Hoc Analysis of Predictors of Clinical Response to Repository Corticotropin Injection in Persistently Active Rheumatoid Arthritis. Fleischmann R; Hayes K; Ahn SW; Wan GJ; Panaccio M; Karlsson D; Furst DE Rheumatol Ther; 2022 Apr; 9(2):649-661. PubMed ID: 35184268 [TBL] [Abstract][Full Text] [Related]
34. ACTH and prostaglandin receptors in human adrenocortical tumors. Apparent modification of a specific component of the ACTH-binding site. Saez JM; Dazord A; Gallet D J Clin Invest; 1975 Sep; 56(3):536-47. PubMed ID: 169292 [TBL] [Abstract][Full Text] [Related]
35. Response of the adrenal cortex to tetracosactrin (ACTH1-24) in the premature and full-term foal. Rossdale PD; Silver M; Ellis L; Frauenfelder H J Reprod Fertil Suppl; 1982; 32():545-53. PubMed ID: 6300391 [TBL] [Abstract][Full Text] [Related]
36. Consequences of insurance denials among U.S. patients prescribed repository corticotropin injection (Acthar Gel) for nephrotic syndrome. Rice JB; Panaccio MP; White A; Simes M; Billmyer E; Downes N; Niewoehner J; Wan GJ Curr Med Res Opin; 2021 Mar; 37(3):431-441. PubMed ID: 33411573 [TBL] [Abstract][Full Text] [Related]
37. Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial. Fleischmann R; Furst DE; Connolly-Strong E; Liu J; Zhu J; Brasington R Rheumatol Ther; 2020 Jun; 7(2):327-344. PubMed ID: 32185745 [TBL] [Abstract][Full Text] [Related]
38. Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar Askanase AD; Wan GJ; Panaccio MP; Zhao E; Zhu J; Bilyk R; Furie RA Rheumatol Ther; 2021 Mar; 8(1):573-584. PubMed ID: 33687687 [TBL] [Abstract][Full Text] [Related]
39. Demographics, treatment patterns, and healthcare utilization and cost of repository corticotropin injection in patients with systemic lupus erythematosus or rheumatoid arthritis. Wu B; Deshpande G; Gu T; Popelar B; Philbin M; Wan GJ J Med Econ; 2017 Nov; 20(11):1170-1177. PubMed ID: 28760047 [TBL] [Abstract][Full Text] [Related]
40. Comparison of the corticotropic action of two synthetic, substituted analogues of ACTH: ACTH1--17 and ACTH1--18. Vierhapper H; Waldhäusl W J Clin Endocrinol Metab; 1978 Jul; 47(1):208-11. PubMed ID: 233661 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]